eligibility for clinicaltrials:NCT01229644 [clinicaltrials_resource:07d1232418b14c15dfaa47d6e245a004]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01229644 [clinicaltrials_resource:07d1232418b14c15dfaa47d6e245a004]
Bio2RDF identifier
07d1232418b14c15dfaa47d6e245a004
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:07d1232418b14c15dfaa47d6e245a004
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... Appendix III) and troglitazone
identifier
clinicaltrials_resource:07d1232418b14c15dfaa47d6e245a004
title
eligibility for clinicaltrials:NCT01229644
@en
type
label
eligibility for clinicaltrials ...... 1232418b14c15dfaa47d6e245a004]
@en